|
1
|
Voduc KD, Cheang MC, Tyldesley S, Gelmon
K, Nielsen TO and Kennecke H: Breast cancer subtypes and the risk
of local and regional relapse. J Clin Oncol. 28:1684–1691. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ades F, Zardavas D, Bozovic-Spasojevic I,
Pugliano L, Fumagalli D, de Azambuja E, Viale G, Sotiriou C and
Piccart M: Luminal B breast cancer: Molecular characterization,
clinical management, and future perspectives. J Clin Oncol.
32:2794–2803. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cheang MC, Chia SK, Voduc D, Gao D, Leung
S, Snider J, Watson M, Davies S, Bernard PS, Parker JS, et al: Ki67
index, HER2 status, and prognosis of patients with luminal B breast
cancer. J Natl Cancer Inst. 101:736–750. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Goldhirsch A, Wood WC, Coates AS, Gelber
RD, Thürlimann B and Senn HJ: Panel members: Strategies for
subtypes-dealing with the diversity of breast cancer: Highlights of
the St. Gallen international expert consensus on the primary
therapy of early breast cancer 2011. Ann Oncol. 22:1736–1747. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goldhirsch A, Winer EP, Coates AS, Gelber
RD, Piccart-Gebhart M, Thürlimann B and Senn HJ; Panel members, :
Personalizing the treatment of women with early breast cancer:
Highlights of the St. Gallen international expert consensus on the
primary therapy of early breast cancer 2013. Ann Oncol.
24:2206–2223. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boisserie-Lacroix M, Hurtevent-Labrot G,
Ferron S, Lippa N, Bonnefoi H and Mac Grogan G: Correlation between
imaging and molecular classification of breast cancers. Diagn
Interv Imaging. 94:1069–1080. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mazurowski MA, Zhang J, Grimm LJ, Yoon SC
and Silber JI: Radiogenomic analysis of breast cancer: Luminal B
molecular subtype is associated with enhancement dynamics at MR
imaging. Radiology. 273:365–372. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aberle DR, Chiles C, Gatsonis C, Hillman
BJ, Johnson CD, McClennan BL, Mitchell DG, Pisano ED, Schnall MD
and Sorensen AG; American College of Radiology Imaging Network, :
Imaging and cancer: Research strategy of the american college of
radiology imaging network. Radiology. 235:741–751. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang L, Li J, Xiao Y, Cui H, Du G, Wang
Y, Li Z, Wu T, Li X and Tian J: Identifying ultrasound and clinical
features of breast cancer molecular subtypes by ensemble decision.
Sci Rep. 5:110852015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brandao AC, Lehman CD and Partridge SC:
Breast magnetic resonance imaging: Diffusion-weighted imaging. Magn
Reson Imaging Clin N Am. 21:321–336. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Padhani AR, Liu G, Koh DM, Chenevert TL,
Thoeny HC, Takahara T, Dzik-Jurasz A, Ross BD, Van Cauteren M,
Collins D, et al: Diffusion-weighted magnetic resonance imaging as
a cancer biomarker: Consensus and recommendations. Neoplasia.
11:102–125. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Basser PJ: Inferring microstructural
features and the physiological state of tissues from
diffusion-weighted images. NMR Biomed. 8:333–344. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Woodhams R, Ramadan S, Stanwell P,
Sakamoto S, Hata H, Ozaki M, Kan S and Inoue Y: Diffusion-weighted
imaging of the breast: Principles and clinical applications.
Radiographics. 31:1059–1084. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Atuegwu NC, Arlinghaus LR, Li X, Welch EB,
Chakravarthy BA, Gore JC and Yankeelov TE: Integration of
diffusion-weighted MRI data and a simple mathematical model to
predict breast tumor cellularity during neoadjuvant chemotherapy.
Magn Reson Med. 66:1689–1696. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoshikawa MI, Ohsumi S, Sugata S, Kataoka
M, Takashima S, Mochizuki T, Ikura H and Imai Y: Relation between
cancer cellularity and apparent diffusion coefficient values using
diffusion-weighted magnetic resonance imaging in breast cancer.
Radiat Med. 26:222–226. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Squillaci E, Manenti G, Di Roma M, Miano
R, Palmieri G and Simonetti G: Correlation of diffusion-weighted MR
imaging with cellularity of renal tumours. Anticancer Res.
24:4175–4179. 2004.PubMed/NCBI
|
|
17
|
Partridge SC, DeMartini WB, Kurland BF,
Eby PR, White SW and Lehman CD: Quantitative diffusion-weighted
imaging as an adjunct to conventional breast MRI for improved
positive predictive value. AJR Am J Roentgenol. 193:1716–1722.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sinha S, Lucas-Quesada FA, Sinha U,
DeBruhl N and Bassett LW: In vivo diffusion-weighted MRI of the
breast: Potential for lesion characterization. J Magn Reson
Imaging. 15:693–704. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fornasa F, Pinali L, Gasparini A, Toniolli
E and Montemezzi S: Diffusion-weighted magnetic resonance imaging
in focal breast lesions: Analysis of 78 cases with pathological
correlation. Radiol Med. 116:264–275. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Malayeri AA, El Khouli RH, Zaheer A,
Jacobs MA, Corona-Villalobos CP, Kamel IR and Macura KJ: Principles
and applications of diffusion weighted imaging in cancer detection,
staging, and treatment follow-up. Radiographics. 31:1773–1791.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Le Bihan D, Breton E, Lallemand D, Grenier
P, Cabanis E and Laval-Jeantet M: MR imaging of intravoxel
incoherent motions: Application to diffusion and perfusion in
neurologic disorders. Radiology. 161:401–407. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Koh DM, Collins DJ and Orton MR:
Intravoxel incoherent motion in body diffusion weighted MRI:
Reality and challenges. AJR Am J Roentgenol. 196:1351–1361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Le Bihan D, Breton E, Lallemand D, Aubin
ML, Vignaud J and Laval-Jeantet M: Separation of diffusion and
perfusion in intravoxel incoherent motion MR imaging. Radiology.
168:497–505. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Suo S, Lin N, Wang H, Zhang L, Wang R,
Zhang S, Hua J and Xu J: Intravoxel incoherent motion
diffusion-weighted MR imaging of breast cancer at 3.0 tesla:
Comparison of different curve-fitting methods. J Magn Reson
Imaging. 42:362–370. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim Y, Ko K, Kim D, Min C, Kim SG, Joo J
and Park B: Intravoxel incoherent motion diffusion-weighted MR
imaging of breast cancer: Association with histopathological
features and subtypes. Br J Radiol. 89:201601402016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sigmund EE, Cho GY, Kim S, Finn M,
Moccaldi M, Jensen JH, Sodickson DK, Goldberg JD, Formenti S and
Moy L: Intravoxel incoherent motion imaging of tumor
microenvironment in locally advanced breast cancer. Magn Reson Med.
65:1437–1447. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Meacham CE and Morrison SJ: Tumour
heterogeneity and cancercell plasticity. Nature. 501:328–337. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fisher R, Pusztai L and Swanton C: Cancer
heterogeneity: Implications for targeted therapeutics. Br J Cancer.
108:479–485. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Polyak K: Heterogeneity in breast cancer.
J Clin Invest. 121:3786–3788. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Iima M, Yano K, Kataoka M, Umehana M,
Murata K, Kanao S, Togashi K and Le Bihan D: Quantitative
non-gaussian diffusion and intravoxel incoherent motion magnetic
resonance imaging: Differentiation of malignant and benign breast
lesions. Invest Radiol. 50:205–211. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu C, Liang C, Liu Z, Zhang S and Huang
B: Intravoxel incoherent motion (IVIM) in evaluation of breast
lesions: Comparison with conventional DWI. Eur J Radiol.
82:e782–e789. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cho GY, Moy L, Kim SG, Baete SH, Moccaldi
M, Babb JS, Sodickson DK and Sigmund EE: Evaluation of breast
cancer using intravoxel incoherent motion (IVIM) histogram
analysis: Comparison with malignant status, histological subtype,
and molecular prognostic factors. Eur Radiol. 26:2547–2558. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Alili C, Pages E, Curros Doyon F,
Perrochia H, Millet I and Taourel P: Correlation between MR
imaging-prognosis factors and molecular classification of breast
cancers. Diagn Interv Imag. 95:235–242. 2014. View Article : Google Scholar
|
|
34
|
Uematsu T, Kasami M and Yuen S:
Triple-negative breast cancer: Correlation between MR imaging and
pathologic findings. Radiology. 250:638–647. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cho GY, Gennaro L, Sutton EJ, Zabor EC,
Zhang Z, Giri D, Moy L, Sodickson DK, Morris EA, Sigmund EE and
Thakur SB: Intravoxel incoherent motion(IVIM) histogram biomarkers
for prediction of neoadjuvant treatment response in breast cancer
patients. Eur J Radiol Open. 4:101–107. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wolff AC, Hammond ME, Hicks DG, Dowsett M,
McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M,
Fitzgibbons P, et al: Recommendations for human epidermal growth
factor receptor 2 testing in breast cancer: American society of
clinical oncology/college of American pathologists clinical
practice guideline update. Arch Pathol Lab Med. 138:241–256. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Weidner N: Intratumor microvessel density
as a prognostic factor in cancer. Am J Pathhol. 147:9–19. 1995.
|
|
38
|
Liu C, Wang K, Chan Q, Liu Z, Zhang J, He
H, Zhang S and Liang C: Intravoxel incoherent motion MR imaging for
breast lesions: Comparison and correlation with pharmacokinetic
evaluation from dynamic contrast-enhanced MR imaging. Eur Radiol.
26:3888–3898. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bokacheva L, Kaplan JB, Giri DD, Patil S,
Gnanasigamani M, Nyman CG, Deasy JO, Morris EA and Thakur SB:
Intravoxel incoherent motion diffusion-weighted MRI at 3.0 T
differentiates malignant breast lesions from benign lesions and
breast parenchyma. J Magn Reson Imaging. 40:813–823. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sigmund EE, Cho GY, Kim S, Finn M,
Moccaldi M, Jensen JH, Sodickson DK, Goldberg JD, Formenti S and
Moy L: Intravoxel incoherent motion imaging of tumor
microenvironment in locally advanced breast cancer. Magn Reson Med.
65:1437–1447. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jeh SK, Kim SH, Kim HS, Kang BJ, Jeong SH,
Yim HW and Song BJ: Correlation of the apparent diffusion
coefficient value and dynamic magnetic resonance imaging findings
with prognostic factors in invasive ductal carcinoma. J Magn Reson
Imaging. 33:102–109. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kamitani T, Matsuo Y, Yabuuchi H, Fujita
N, Nagao M, Jinnouchi M, Yonezawa M, Yamasaki Y, Tokunaga E, Kubo
M, et al: Correlations between apparent diffusion coefficient
values and prognostic factors of breast cancer. Magn Reson Med Sci.
12:193–199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kim SH, Cha ES, Kim HS, Kang BJ, Choi JJ,
Jung JH, Park YG and Suh YJ: Diffusion-weighted imaging of breast
cancer: Correlation of the apparent diffusion coefficient value
with prognostic factors. J Magn Reson Imaging. 30:615–620. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Huuse EM, Moestue SA, Lindholm EM, Bathen
TF, Nalwoga H, Krüger K, Bofin A, Maelandsmo GM, Akslen LA,
Engebraaten O and Gribbestad IS: In vio MRI and histopathological
assessment of tumor microenvironment in luminal-like and basal-like
breast cancer xenografts. J Magn Reson Imaging. 35:1098–1107. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang SJ, Hu Y, Qian HL, Jiao SC, Liu ZF,
Tao HT and Han L: Expression and significance of ER, PR, VEGF,
CA15-3, CA125 and CEA in judging the prognosis of breast cancer.
Asian Pac J Cancer Prev. 14:3937–3940. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Noh S, Kim do H, Jung WH and Koo JS:
Expression levels of serine/glycine metabolishm-realted proteins in
triple negative breast cancer tissues. Tumor Biol. 35:4457–4468.
2014. View Article : Google Scholar
|
|
47
|
Biesaga B, Niemiec J and Ziobro M:
Microvessel density and status of p53 protein as potential
prognostic factors for adjuvant anthracycline chemotherapy in
restrospective analysis of early breast cancer patients group.
Pathol Oncol Res. 18:949–960. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dai X, Chen A and Bai Z: Integrative
investigation on breast cancer in ER, PR, and HER2-defined
subgroups using mRNA and miRNA expression profiling. Sci Rep.
4:65662014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mori N, Ota H, Mugikura S, Takasawa C,
Ishida T, Watanabe G, Tada H, Watanabe M, Takase K and Takahashi S:
Luminal-type breast cancer: Correlation of apparent diffusion
coefficients with the Ki-67 labeling index. Radiology. 274:66–73.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Holowatyj AN, Ruterbusch JJ, Ratnam M,
Gorski DH and Cote ML: HER2 status and disparities in luminal
breast cancers. Cancer Med. 5:2109–2116. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Uematsu T: MR imaging of triple-negative
breast cancer breast cancer. Breast Cancer. 18:161–164. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Vranic S, Frkovic-Grazio S, Bilalovic N
and Gatalica Z: Angiogenesis in triple-negativeadenoid cystic
carcinomas of the breast. Virchows Arch. 459:377–382. 2011.
View Article : Google Scholar : PubMed/NCBI
|
